Healthcare & Biotech

Boston – September 17, 2026 -- Outcomes4Me Inc. has appointed Jim Longley, formerly Senior Vice President of AI Partnerships at OpenEvidence, as its new Chief Revenue Officer to lead commercial expansion across pharma, provider, and diagnostic partnerships.

Longley brings two decades of health tech revenue scaling to the role

Before OpenEvidence, Longley spent nearly five years at GoodRx, rising to Senior Vice President and Head of Commercial, and prior to that spent over six years at Doximity as Vice President for Business Development and Product Innovation. Outcomes4Me CEO Maya R. Said, Sc.D., said Longley has a track record of scaling health tech companies to hundreds of millions of dollars in revenue.

Dublin – September 16, 2026 -- Davion Healthcare Plc has secured admission of a £30 million senior secured bond to trading on the Vienna MTF, operated by Wiener Börse AG, giving the Irish healthcare group a dedicated capital pool to fund acquisitions.

Bond carries 10.5% fixed coupon over five-year term

The bond, issued through financing subsidiary Davion Healthcare Finance Ltd, commenced in August 2026 and carries a fixed annual coupon of 10.5%. It trades under ISIN GB00BTH2SB89, with a denomination of £100,000 per unit.

Proceeds target acquisitions across five healthcare segments

Davion plans to deploy the capital toward acquiring established, cash-generative businesses in medical devices, diagnostics, medical distribution, healthcare technology and healthcare services. Proceeds are released on an acquisition-by-acquisition basis through Davion Healthcare Finance Ltd, with security granted over each acquired asset.

Aubonne – September 16, 2026 -- Intuitive has secured CE mark approval for its da Vinci SP surgical system to perform transvaginal gynecologic procedures, marking the first such indication for the Single Port platform anywhere in the world.

Approval widens da Vinci SP's European surgical scope beyond five existing categories

The new indication adds to da Vinci SP's current CE-marked applications in Europe, which cover endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, transanal colorectal, and breast procedures. The system now supports natural orifice surgery across transoral, transanal, and transvaginal routes.

Denver – September 16, 2026 -- The International Association for the Study of Lung Cancer (IASLC) has launched a Complimentary IASLC Full Membership program for healthcare professionals in World Bank-designated low-income and lower-middle-income economies, eliminating financial barriers to its global thoracic oncology network.

Board approves fee waiver to widen access to research and clinical resources

The IASLC Board of Directors approved the initiative this spring, extending full membership benefits at no cost to clinicians, researchers, nurses, allied health professionals and patient advocates in eligible countries. Eligibility is determined annually using World Bank country income classifications.

Berlin – September 16, 2026 -- Aignostics has opened early access to PathoSearch, a visual search engine that retrieves diagnosed reference pathology cases from a single screenshot of an H&E slide, targeting the rare and complex cases that make up as much as 20% of a pathologist's caseload.

Database already spans 310,000 slides across 300 diagnostic entities

PathoSearch currently references more than 310,000 whole slide images drawn from over 35,000 cases, covering 300-plus diagnostic entities and 27-plus organs. The system is on track to exceed one million whole slide images by general availability. Coverage follows the WHO Classification of Tumours, focusing on malignant tumours across five organ groups -- thoracic, digestive, soft tissue and bone, female genital, and urinary and male genital -- with full coverage of all WHO-classified malignancies planned.

Boston – September 16, 2026 -- PerZeption Inc. has secured a Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute to fund development of a new photostress recovery test for age-related macular degeneration (AMD), a condition affecting an estimated 20 million people in the United States.

NEI Funds Photostress Recovery Test for Earlier AMD Detection

The award backs the project "Efficient Achromatic and Chromatic Photostress Recovery Assessment for Age-related Macular Degeneration," which will be carried out in collaboration with researchers at the Brunson Center for Translational Vision Research at the University of California, Irvine. The work targets how quickly vision recovers after bright-light exposure, a marker of macular health that can reveal functional deficits before they show up on standard acuity tests.

Cordova, Tenn. – September 16, 2026 -- Aesthetic Management Partners (AMP) has added ATTIVA®, an intelligent subdermal radiofrequency platform developed by Italy's Tema Medicina S.R.L., to its aesthetic technology portfolio, the company announced.

ATTIVA delivers controlled thermal energy beneath the skin to remodel tissue

The platform uses a fine, insulated cannula to deliver radiofrequency energy into subdermal tissue, producing immediate collagen contraction while supporting progressive collagen and elastin regeneration. It targets the face, neck, jawline, submental area and body, and is designed as a minimally invasive option with limited downtime for most patients.

Plantation, Fla. – September 16, 2026 -- LUX Infusion has acquired two ambulatory infusion centers, South Jersey Pediatric and Adult Infusion Center in Cherry Hill, New Jersey, and Northeast Infusion Therapy in Latham, New York, expanding its clinician-led network into two new states.

LUX Infusion adds two ambulatory infusion centers to its national network

The Plantation, Florida-based company, a portfolio holding of Frazier Healthcare Partners, said the acquisitions extend its footprint of ambulatory infusion centers (AICs) focused on physician-ordered and medically prescribed infusion therapies.

South Jersey center serves both pediatric and adult patients in Cherry Hill

South Jersey Pediatric and Adult Infusion Center delivers physician-ordered infusion services in an outpatient setting serving both pediatric and adult populations, with emphasis on medical supervision and coordination with referring physicians.

Madison, Wis. – September 16, 2026 -- Accuray Incorporated (NASDAQ: ARAY) and RaySearch Laboratories AB (publ) have signed a definitive agreement expanding their collaboration to accelerate adoption of online adaptive radiation therapy, with Accuray committing to purchase RayStation software licenses valued at $8 million.

Accuray commits $8 million to RaySearch software licenses

Under the deal, Accuray will buy specified RayStation licenses to support commercialization of online adaptive radiation therapy solutions, which both companies will jointly market and support. The agreement also brings RaySearch's RayCare technology into the partnership to simplify connectivity between clinical systems and streamline adaptive workflows.

Toronto – September 16, 2026 -- iGan Partners, a Toronto-based venture capital firm focused on medical device, diagnostic, imaging, and digital health companies, disclosed a series of portfolio milestones, headlined by a development contract worth up to $70 million awarded to portfolio company Flosonics Medical.

Flosonics secures BARDA contract to extend ultrasound tech into trauma care

The contract, from the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services, includes approximately $15 million in initial funding. It supports FloPredict, an AI-enabled software enhancement to Flosonics' FDA-cleared FloPatch device, expanding the real-time ultrasound technology into trauma care and mass casualty response applications.